Skip to main content
Clinical Trials/NCT02174081
NCT02174081
Completed
Not Applicable

ARDS Prediction Score in Critically Ill Patients in China

Jianfeng Xie1 site in 1 country698 target enrollmentMarch 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ARDS
Sponsor
Jianfeng Xie
Enrollment
698
Locations
1
Primary Endpoint
incidence of ARDS
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

ARDS is a severe disease, it's important to predict the incidence of ARDS.

Detailed Description

From January 1 to January 31, 2012 and from January 1 to January 10, 2013 , all patients admit to the ICUs will be enrolled. The demographic characteristics, diagnosis, formerly medical history, Ventilator indications, Ventilator data, other respiratory treatments, weaning outcome and 28 day mortality will be recorded.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
June 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Jianfeng Xie
Responsible Party
Sponsor Investigator
Principal Investigator

Jianfeng Xie

Zhongda Hospital

Southeast University, China

Eligibility Criteria

Inclusion Criteria

  • Critically ill patients who admitted into participating ICU

Exclusion Criteria

  • Patients with chronic pulmonary disease such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, pulmonary fibrosis and tuberculosis Age less than 18 years old Pregnancy Died within 24 hours from ICU admission ARDS patients who diagnosed 24hours before ICU admission Referral from other hospital to participating ICU Lack of data of ARDS risk factors

Outcomes

Primary Outcomes

incidence of ARDS

Time Frame: up to 24 months

evaluate the incidence of risk factors of ARDS

Study Sites (1)

Loading locations...

Similar Trials